ERBB-3 (HER3)-selective combination therapy

Details for Australian Patent Application No. 2009313510 (hide)

Owner Santaris Pharma A/S Enzon Pharmaceuticals, Inc.

Inventors Liao, Baisong; Zhang, Yixian

Agent Griffith Hack

Pub. Number AU-A-2009313510

PCT Pub. Number WO2010/054051

Priority 61/112,549 07.11.08 US

Filing date 5 November 2009

Wipo publication date 14 May 2010

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 5/02 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/054051 Priority application(s): WO2010/054051

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009313524-Gamma secretase modulators

2009313509-Variable PHY margin to combat ingress noise